GSK’s $2.2 billion Zantac settlement today put its shares top of the FTSE 100, albeit still well short of their level before ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

London’s FTSE 100 was down 6.01 points, or 0.07%, to close at 8,237.73, with housebuilders among the stocks dragging on the ...

Healthcare & Pharmaceuticalscategory Pfizer's cancer drug combo improves overall survival in late-stage study 10:47 AM UTC Healthcare & Pharmaceuticalscategory GSK shares jump on $2.2 billion Zantac ...

Thursday saw choppy trading across European stock markets with the region's main benchmark finishing lower but moving within a narrow range, as investors focused on mixed economic data from the US and ...

(Reuters) -European shares closed lower on Thursday, with defence and industrial stocks leading losses, after data showed U.S ...

(Sharecast News) - London's stock markets ended ... announcing a $2.2bn settlement to resolve around 80,000 Zantac lawsuits in the US. The settlement covered 93% of state court cases, with GSK also ...

Shares slipped in New York and Europe Thursday as the latest US inflation report strengthened the case for a slower pace of ...

Lawyers representing 10 groups of plaintiffs, or 80,000 liability cases across the US, have backed the payout. There remain another few thousand cases not covered by the payout. GSK will also pay a ...

European shares ended slightly lower, driven by losses in defence and industrial sectors, amid rising U.S. inflation and ...